Module 2.1 – SARS-CoV-2 sequencing in Arizona

What to know

This case study from Arizona provides insight into how SARS-CoV-2 sequencing is used to describe the genomic epidemiology of a state and as an investigative tool in COVID-19 outbreak settings.

thumbnail for module 2.1

Overview

Presenter: Hayley Yaglom, MS, MPH | Genomic Epidemiologist, Translational Genomics Research Institute
View Presentation |

You can read more about this work:

Further Reading

  1. Ladner, et al. mBio, 2020.
  2. . Arizona COVID Genomics Union (ACGU).

Additional Resources

  1. Nextstrain.org (documentation).
  2. Fauver, et al. Cell, 2020.
  3. Page, et al. Microb Genom, 2021.
  4. Mueller, et al. Sci Transl Med, 2021.
  5. Moreno, et al. Nat Commun, 2020.
Print
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)